in association with

 Future of healthcare:
What will medicine look
like in 2040?

Advances in medical technologies are laying the groundwork for a dramatic transformation in how health issues are diagnosed, managed and treated over the next few decades. Ellen Daniel hears from futurologist Ray Hammond to find out what is on the horizon.

T

he year is 2040. You go into hospital for a routine surgery, but unlike today, this is performed by a surgeon operating remotely from a different continent, using new blood generated inside your own body without the need for a blood donor, using medicine specifically designed to match your own DNA.

These are just some of the ways futurologist Ray Hammond envisions healthcare will change over the next 20 years and beyond.

Although it is impossible to know the extent to which medical care will have changed over the next two decades, Hammond, who has written 14 books on the future, has envisioned a tomorrow in which medical care is increasingly personalised, digitally focused and data-driven.

Part of ‘The World in 2040’ futurology series, Hammond’s report outlines five main ways the healthcare landscape might change: personalised medicine, stem-cell medicine, nanoscale medicine, gene therapy and editing and digital health.

Although these advances are already having an impact on healthcare, they are still at their early stages, but due to advances in AI, the falling cost of gene sequencing and personalised medicine, they are fast becoming key parts of diagnostics, drug development and patient care.

Over the last few years, the world of healthcare has become increasingly focused on what cutting-edge technology can offer patients and physicians. In 218, the UK Government launched The Future of Healthcare, a commitment to advancing the NHS’s digital services and IT systems.

But how will this continue to change over the next 20 years?

Profound change ahead

In the next 20 years, the current “one size fits all” approach to medicine could be replaced, thanks to advances in personalised medicine or precision medicine. Analysis of individuals’ DNA may mean that doctors can start to treat patients with drugs tailored to their own DNA.

DNA sequencing will also have an impact on disease diagnosis and prediction. The report explains that by 2040, 2040 medical science will have collected DNA sequencing data from tens of millions of patients, shedding light on associations between particular genes and diseases.

By 2040, Hammond predicts that every newborn baby will have their DNA routinely sequenced.

Stem-cell medicine, which is at the early stages currently, will become an important tool in mainstream medicine. For example, rather than relying on donors for human organs, they will be grown on demand from stem cells in the lab.

Hammond also predicts that in the future, medical care could be taking place at a nanoscale. Nano medicine, the use of nanomaterials for diagnosis and drug delivery, will have advanced beyond the early stages it is at today. In 2040, scientists may be able to manipulate cells at a molecular level, allowing for an even greater level of personalisation.

By 2040, Hammond predicts that every newborn baby will have their DNA routinely sequenced.

Although currently an ethical grey area, gene editing, in which the genes responsible for certain medical conditions are deactivated or rewritten, will likely remain a central debate in the medical field for years to come.

As the internet of things connects a growing number of objects, “smart bodies” are predicted to become a common part of patient care. Sensors in or on patients’ bodies will allow physicians to monitor patients in real-time for things such as blood pressure, blood glucose levels, or potassium levels, and will provide early warnings if something goes wrong. The data this will generate could then be used to further personalise treatments for individual patients.

Another trend that is accelerating rapidly is digital healthcare. In 2040, Hunter predicts that ‘chatbots’ utilising deep learning will be on-hand to assist patients with medical queries, relieving GPs and A&E services in non-emergency situations.

As costs fall and capabilities advance, by 2040 it may be common for surgeries to be carried out by machines under human supervision. With improvements in the speed of network communications, this may eventually mean that a surgeon could perform surgery on a patient from thousands of miles away.

A rise in healthcare spending

As prevalence of health-related technologies grows, so will healthcare spending. The annual global healthcare market is currently estimated to be worth around $8.1tn, with annual global spending on healthcare forecast to rise to $18.28tn by 2040.

However, Hammond believes that the future of healthcare is dependent on the willingness of the medical science field to embrace change.

Healthcare is one of the few arenas in which every one of us has a stake.

“Healthcare is one of the few arenas in which every one of us has a stake. The next 20 years will witness profound change in healthcare, all the more notable given that medical science and healthcare delivery tend to be conservative, slow-moving sectors that are highly resistant to change,” he said.

“We have a collective responsibility to ourselves and to the next generation to determine what that change will look like and the impact it will have on all of us.”

Go to article: Home | Deep Space DiagnosticsGo to article: In this issueGo to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: Contents Go to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: Critical Software Company Insight Go to article: Critical SoftwareGo to article: NewsGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: Omnitron Go to article: The Medical Industry Briefing Go to article: Sab BroeckskesGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Exceeding expectations: home sperm testing in the fertility tech marketGo to article: Siemens Company Insight Go to article: Siemens Go to article: Micro Systems TechnologiesGo to article: Space simulation: how gaming tech is being used to medically train astronautsGo to article: Braxton Manufacturing Go to article: CaelesteGo to article: Duodenoscopes: a dirty problemGo to article: Nelson Labs Company InsightGo to article: Nelson Labs Go to article: Mobile mind control: material engineering meets neurobiology Go to article: Abbott & CoGo to article: IMT Company InsightGo to article: IMTGo to article: Breathe easy: improving at-home asthma managementGo to article: Erdmann Design Company Insight Go to article: Erdmann Design Go to article: Q&A: the challenge of foetal monitoring with Professor Barrie Hayes-GillGo to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: Roundtable: debating the benefits of the NHS’s newly launched AI labGo to article: Europlasma Company Insight Go to article: EuroplasmaGo to article: The long road to reliable organ printingGo to article: SartoriusGo to article: Cap BiomaterialsGo to article: URGENT/11 vulnerabilities showcase cybersecurity risks for connected medical devicesGo to article: Telemed Company InsightGo to article: TelemedGo to article: Admedus turns focus to TAVR market with next-generation tissue technologyGo to article: Turck Duotec Company Insight Go to article: Turck DuotecGo to article: 3BYGo to article: Medtronic’s extravascular ICD is pushing innovationGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO Go to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Obstacle course for sperm is helping IVF scientists find the best swimmersGo to article: MicronovaGo to article: ARPA Company InsightGo to article: ARPAGo to article: Varian enters the embolisation particles marketGo to article: Ginolis Company InsightGo to article: GinolisGo to article: Verdict Insights: The latest verdict insight from Medical Technology Go to article: TEN MedPrint Company Insight Go to article: TEN MedPrint Go to article: Future of healthcare: What will medicine look like in 2040?Go to article: GF Machining Solutions Company InsightGo to article: GF Machining Solutions Go to article: 3D printing: Bringing assistive technology to the developing worldGo to article: iTAC Software Go to article: CarmoGo to article: Stepping up anatomical 3D printingGo to article: Key Plastics Company Insight Go to article: Key PlasticsGo to article:  Coaxial Electrospinning: Revolutionising MedicineGo to article: SARA: The robot targeting European elderly careGo to article: ClippardGo to article: Bright PlasticsGo to article: Asahi InteccGo to article: Bias in the system: the leading healthcare algorithm with bias against black patientsGo to article: Mdeg Digital Go to article: Maraca InternationalGo to article: OptelGo to article: Body cameras: The benefits in mental healthcareGo to article: CleanControlling MedicalGo to article: Abatek InternationalGo to article: XavitechGo to article: Take a seat: The mental health chatbots encroaching on the therapist’s couchGo to article: mdi ConsultantsGo to article: MK FluidicsGo to article: AI for sight: The technology transforming infant eye disorder diagnosisGo to article: ProByLas Go to article: ITV Denkendorf ProduktserviceGo to article: Deals in brief powered by GlobalDataGo to article: TS Quality & EngineeringGo to article: Mi3 Medical IntelligenceGo to article: The key list powered by GlobalDataGo to article: AerogelexGo to article: EventsGo to article: PI CeramicGo to article: Next issueGo to article: Qmedics Company Insight Go to article: QmedicsGo to article: Tresky